Loading clinical trials...
Loading clinical trials...
An Open-Label, Phase 2 Study of the Latanoprost Punctal Plug Delivery System (L-PPDS) With Adjunctive Xalatan® Eye Drops in Subjects With Ocular Hypertension (OH) or Open-Angle Glaucoma (OAG)
Conditions
Interventions
Latanoprost Punctal Plug Delivery System
Xalatan
Locations
1
United States
Menlo Park
Menlo Park, California, United States
Start Date
December 1, 2009
Primary Completion Date
April 1, 2010
Completion Date
July 1, 2010
Last Updated
January 10, 2014
NCT07390890
NCT05902871
NCT07218796
NCT07119580
NCT06865144
NCT06689696
Lead Sponsor
Mati Therapeutics Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions